Moderna Vaccine Booster

Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

Reuters · 6h

US awards Moderna $590 million for bird flu vaccine development

The U.S. government has awarded Moderna $590 million to advance the late-stage development of its mRNA bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.

CNN on MSN · 4h

HHS invests nearly $600 million in Moderna’s bird flu vaccine development

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu, the pharmaceutical company announced Friday.

The Wall Street Journal on MSN · 5h

Moderna Gets $590 Million of Federal Funding For Influenza Vaccines

The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the company said

Barron's on MSN · 5h

Moderna Is Getting $590 Million From the U.S. to Accelerate a Bird Flu Vaccine

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Moderna cuts 2025 sales forecast by $1 bln on weak vaccine demand, shares tumble

Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...

Monthly Prescribing Reference3d

Moderna Provides Update on Norovirus Vaccine Candidate

Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial investigating a ...

1don MSN

Northeast Ohio pediatrician’s office working with Moderna on a potential mono vaccine

The research team at Senders Pediatrics is working with Moderna to study a vaccine developed for Epstein-Barr Virus, which ...

FiercePharma4d

JPM25: Moderna slashes guidance, plots $1B in cost cuts this year amid lackluster vaccine sales

Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s ...

1don MSN

CDC upgrades its advisory on bird flu. Will Moderna’s stock get a boost?

CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...

1don MSN

Moderna Dropped by 20% This Week -- Is It a Smart Buy Right Now?

The main reason for this week's decline is that Moderna lowered its 2025 full-year revenue guidance, and by a wide margin.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results